awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26771518-9F9BC2A3-52A3-46C8-BDB8-20E954799236
Q26771518-9F9BC2A3-52A3-46C8-BDB8-20E954799236
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771518-9F9BC2A3-52A3-46C8-BDB8-20E954799236
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
P2860
Q26771518-9F9BC2A3-52A3-46C8-BDB8-20E954799236
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771518-9F9BC2A3-52A3-46C8-BDB8-20E954799236
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b6257549c78c0beaea321aa64f2512184e91439b
P2860
Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.